Only three of eight patients (38%) with cirrhosis but without ascites (group Ia) showed elevated serum values of CA 125. However, 21 of 22 patients (95%) with cirrhotic ascites (groups Ib and Ic) had ...

A public biotech company developing cell-encapsulation therapies using its live-cell encapsulation platform to treat cancer, ...

LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell ...

Feasibility and dynamics of preoperative circulating tumor DNA in patients with gastroesophageal cancer receiving preoperative treatment. This is an ASCO Meeting Abstract from the 2023 ASCO ...

The effects of pre-existing psychiatric disorders on gastric cancer survival. Real-world (RW) effectiveness of nivolumab plus chemotherapy (NIVO+chemo) in patients (pts) with advanced or metastatic ...

Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosisFeedback from hepatology community supports US market potential from this ...

Paracentesis is a medical procedure that doctors perform to drain fluid from a person’s abdominal cavity. It is sometimes called an abdominal tap. Doctors refer to this buildup of fluid as ascites, ...

MUNICH, GERMANY, AND BASILDON, UK / ACCESS Newswire / February 13, 2025 / LINDIS Biotech GmbH, a clinical stage biopharmaceutical company with a proprietary multi-specific antibody platform and an ...

A total of 70 consecutive patients were enrolled and divided into three groups. Group I consisted of 30 patients with various types of liver cirrhosis (mean age 65 ± 16 years, range 33-70 years; 15 ...